No Data
Guosen: Focus on AI + Medical, high-quality innovation, and value symbols with stable performance.
Guosen remains bullish on companies with differentiated innovation capabilities and overseas potential.
Beijing Strong Biotechnologies, Inc. (300406.SZ) has obtained a registration certificate for a medical instrument.
Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that the company has received the "Medical Device Registration Certificate" issued by the Beijing Municipal Bureau of Pharmaceutical Affairs...
Beijing Strong Biotechnologies, Inc. (300406.SZ): China National Pharmaceutical Investment has cumulatively increased its Shareholding by 4.3408 million shares, and the increase has been completed.
On December 24, Gelonghui reported that Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that on December 24, 2024, it received a letter from China Meheco Group, a shareholder holding more than 5% of the shares, regarding the implementation of the Shareholding plan. As of the date of this announcement, the Shareholding plan has been completed, with China Meheco Group increasing its shares by a total of 4,340,800 shares through centralized bidding, accounting for 0.74% of the company's shares with voting rights, with an increase amounting to 62,283,792.00 yuan.
Beijing Strong Biotechnologies, Inc. (300406.SZ) obtained multiple medical instruments registration certificates.
Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that the company has received the "Medical Device Registration Certificate" issued by the Beijing Municipal Bureau of Pharmaceutical Affairs...
Jiujiang Biotech: Report for the third quarter of 2024
Beijing Strong Biotechnologies, Inc. (300406.SZ) released its performance for the first three quarters, with a net income of 0.373 billion yuan, a 0.56% increase.
Beijing Strong Biotechnologies, Inc. (300406.SZ) released its third quarter report for 2024, with the company's revenue for the first three quarters reaching 1...